Notably, in HER2-positive breast cancer patients, high PLCH1 expression was also correlated with significantly reduced OS (Figure 2E), RFS (Figure 2F), and DMFS (Figure 2G). This evidence concerns the gene PLCH1 and breast carcinoma.